drugset / Trial / NCT06476704

Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas

NCT06476704 ↗

Phase 2 Not yet recruiting 42 enrolled Centre Paul Strauss LEAF4Life, Inc. · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

This is phase II randomized, multicenter study of treatment with L-TC and preoperative HFRT in patients who were aged 18 years or older with documented localised or locally advanced soft-tissue sarcoma of the extremity. Eligible patients will be randomly assigned 2:1 to receive a preoperative HFRT alone (Arm A) or L-TC with preoperative HFRT (Arm B).

Timeline

Start
2026-07-01
Primary completion
2028-10-15
Completion
2033-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Administration of L-TC Unknown 300 mg Intravenous

Indications